Adjuvant Everolimus in High-Risk Hepatocellular Carcinoma After Curative Resection (SEVERANCE Trial)

Clinical trial NCT06972758 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06972758
Sponsor: Yonsei University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinom Hepatocellular

Start date: 2025-07-01
Primary completion: 2030-07-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.